Fund Holdings — Artia Global Partners LP

Total Portfolio Value:
$443.52M
Total Bought:
$58.84M
Total Sold:
$226.81M
Net Transaction:
-$167.97M
Notable People:
Onusa Nmn Chantanapongwanij, Artia Global Partners Gp Llc
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)682,212628,712-53,500$118.73M$102.81M23.18%-$15.93M
ABIVAX Société AnonymeADS(ABVX)600,747600,7470$81.01M$66.89M15.08%-$14.12M
Eli Lilly and Company(LLY)50,50038,220-12,280$54.27M$35.15M7.93%-$19.12M
Trevi Therapeutics, Inc.(TRVI)2,013,6022,013,6020$25.21M$24.02M5.42%-$1.19M
argenx SEADR(ARGX)64,69929,739-34,960$54.41M$21.72M4.90%-$32.69M
AstraZeneca PLC(AZN)095,376+95,376$0$18.81M4.24%+$18.81M
Newamsterdam Pharma Company
ORDINARY SHARES
503,936503,9360$17.68M$16.13M3.64%-$1.55M
Dianthus Therapeutics, Inc.(DNTH)205,090162,990-42,100$8.45M$13.68M3.08%+$5.23M
Revolution Medicines, Inc.(RVMD)104,190124,990+20,800$8.30M$12.16M2.74%+$3.86M
Ionis Pharmaceuticals, Inc.(IONS)144,376144,3760$11.42M$10.84M2.44%-$580.4K
EyePoint, Inc.(EYPT)767,098767,0980$14.01M$9.89M2.23%-$4.13M
Quest Diagnostics Incorporated(DGX)40,81740,8170$7.08M$8.00M1.80%+$916.3K
Alumis Inc0325,046+325,046$0$7.16M1.61%+$7.16M
Viking Therapeutics, Inc.(VKTX)719,365180,731-538,634$25.31M$5.88M1.33%-$19.43M
Merck & Co., Inc.(MRK)046,700+46,700$0$5.62M1.27%+$5.62M
Terns Pharmaceuticals Inc0104,800+104,800$0$5.53M1.25%+$5.53M
Johnson & Johnson(JNJ)022,600+22,600$0$5.52M1.25%+$5.52M
Sionna Therapeutics, Inc.(SION)119,741119,7410$4.93M$4.80M1.08%-$125.7K
Scholar Rock Holding Corporation(SRRK)96,28596,2850$4.24M$4.73M1.07%+$492.0K
Rapport Therapeutics, Inc.(RAPP)138,508138,5080$4.20M$4.33M0.98%+$131.6K
Ascendis Pharma A/SADR(ASND)17,74017,7400$3.78M$4.06M0.91%+$274.8K
Belite Bio, IncADS(BLTE)17,98924,989+7,000$2.88M$3.98M0.90%+$1.11M
Xenon Pharmaceuticals Inc.(XENE)40,00065,000+25,000$1.79M$3.78M0.85%+$1.99M
Mineralys Therapeutics, Inc.(MLYS)137,800137,8000$5.00M$3.73M0.84%-$1.27M
Roivant Sciences Ltd.SHS(ROIV)129,800129,8000$2.82M$3.60M0.81%+$778.8K
Palisade Bio, Inc.(PALI)1,992,3671,992,3670$4.68M$3.49M0.79%-$1.20M
Biogen Inc.(BIIB)018,437+18,437$0$3.38M0.76%+$3.38M
ProKidney Corp.CL A(PROK)1,838,4111,806,939-31,472$4.12M$3.23M0.73%-$883.6K
AbbVie Inc.(ABBV)14,50014,5000$3.31M$3.15M0.71%-$159.5K
United Therapeutics Corporation(UTHR)5,0005,0000$2.44M$2.96M0.67%+$528.6K
Bright Minds Biosciences Inc.(DRUG)33,40738,407+5,000$2.61M$2.80M0.63%+$195.5K
Protagonist Therapeutics Inc22,95122,931-20$2.00M$2.42M0.54%+$412.4K
Soleno Therapeutics Inc533,69868,490-465,208$24.71M$2.29M0.52%-$22.42M
BrightSpring Health Services, Inc.(BTSG)41,60053,800+12,200$1.56M$2.29M0.52%+$734.5K
Travere Therapeutics, Inc.(TVTX)70,70070,7000$2.70M$2.10M0.47%-$601.0K
Edgewise Therapeutics, Inc.(EWTX)065,500+65,500$0$2.06M0.47%+$2.06M
Celcuity Inc.(CELC)12,90015,576+2,676$1.29M$1.78M0.40%+$491.2K
BridgeBio Pharma, Inc.(BBIO)20,40020,4000$1.56M$1.51M0.34%-$45.5K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)29,20029,2000$1.20M$1.41M0.32%+$201.5K
Cytokinetics, Incorporated(CYTK)016,300+16,300$0$1.07M0.24%+$1.07M
Enliven Therapeutics Inc020,900+20,900$0$819.3K0.18%+$819.3K
Praxis Precision Medicines, Inc.(PRAX)2,5002,5000$736.9K$805.5K0.18%+$68.6K
Tenax Therapeutics, Inc.(TENX)42,08042,0800$513.0K$672.9K0.15%+$159.9K
Kodiak Sciences Inc.(KOD)17,01917,0190$475.9K$648.8K0.15%+$172.9K
Nuvalent Inc8,1004,900-3,200$814.8K$502.0K0.11%-$312.8K
Apogee Therapeutics Inc05,886+5,886$0$495.4K0.11%+$495.4K
Avalo Therapeutics, Inc.(AVTX)41,57028,970-12,600$754.9K$432.5K0.10%-$322.4K
PepGen Inc.(PEPG)205,324205,3240$1.34M$363.4K0.08%-$973.2K
Alnylam Pharmaceuticals, Inc.(ALNY)17,4000-17,400$6.92M$0—-$6.92M
Alto Neuroscience, Inc.(ANRO)29,1920-29,192$519.6K$0—-$519.6K
Lyra Therapeutics Inc8,7560-8,756$27.0K$0—-$27.0K
Ocular Therapeutix, Inc.(OCUL)141,0610-141,061$1.71M$0—-$1.71M
Palvella Therapeutics, Inc.(PVLA)59,2000-59,200$6.20M$0—-$6.20M
uniQure N.V.SHS(QURE)1,023,5390-1,023,539$24.49M$0—-$24.49M
Avidity Biosciences Inc60,1000-60,100$4.34M$0—-$4.34M
ProShares Ultra SilverULTRA GOLD(AGQ)442,1190-442,119$24.55M$0—-$24.55M
Upstream Bio, Inc.(UPB)68,6530-68,653$1.86M$0—-$1.86M
Ventyx Biosciences Inc695,9820-695,982$6.28M$0—-$6.28M
Cidara Therapeutics Inc70,8240-70,824$15.64M$0—-$15.64M
AstraZeneca PLCADR(AZN)190,7520-190,752$17.54M$0—-$17.54M
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q1 2026 | TickerTrail